MIM
VCYT icon

Macroview Investment Management’s Veracyte VCYT Stock Holding History

Macroview Investment Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-130
Closed -$4K – 337
2019
Q2 		$4K Buy
+130
New +$3.25K 0.01% 213

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Macroview Investment Management's VCYT Position: Q3 2019 in Review

Macroview Investment Management sold out of Veracyte (VCYT) in Q3 2019, closing a stake of 130 shares — an estimated $4K sold.

Macroview Investment Management first reported a position in VCYT in Q2 2019 and held it in 1 quarter. The position peaked at $4K in Q2 2019. 187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

  • Macroview Investment Management reported no remaining Veracyte position as of Q3 2019 after selling out during the quarter.
  • Macroview Investment Management sold 130 Veracyte shares in Q3 2019, an estimated $4K.
  • Macroview Investment Management first reported a position in Veracyte in Q2 2019 and held it in 1 quarter.
  • Macroview Investment Management's Veracyte position peaked at $4K in Q2 2019.
  • 187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on Macroview Investment Management's 13F filing for Q3 2019, filed 4 Nov 2019.